As thought-leaders in biomedical ethics we promote the ethical development and delivery of precision child health

Today, children and adolescents increasingly face complex healthcare decisions related to genomic sequencingemerging therapiesinfectious diseases, and the rapid expansion of artificial intelligence (AI) in medical care.

These developments raise profound ethical implications, including:

  • Informed consent
  • Privacy
  • Equity of access
  • Parental decision-making
  • Long-term impacts on children’s welfare and autonomy

Our research focus

Our research group explores critical ethical questions at the intersection of advanced healthcare technologiespaediatric medicine, and reproductive health.

The overarching challenge we address is ensuring the ethical integration of innovative medical interventions that significantly affect children, adolescents, and their families.

Our research goal

We aim to improve healthcare experiences and outcomes for children and adolescents by ensuring that emerging technologies and treatments are used responsibly. Our work seeks to protect and advance the welfareautonomy, and rights of young people.

Our methodologies

Our team uses a combination of:

  • Qualitative research
  • Quantitative research
  • Philosophical analysis

Through rigorous investigation of the ethical dimensions of paediatric and reproductive medicine, our research:

  • Informs policy
  • Guides clinical practice
  • Promotes ethically sound decision-making frameworks

Our research team

We bring together a multidisciplinary team of social scientists, healthcare professionals, legal researchers and health economists to carry out an innovative programme of research.

This work analyses the ethical, legal, social and economic issues raised by genomic sequencing in children.

Contact us

Dr Christopher Gyngell, Team Leader/Honorary Fellow Manager
Phone: show phone number
Email: